Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients

被引：0

作者：

Kubiczkova-Besse, Lenka ^{[1
,2
]}

Drandi, Daniela ^{[3
]}

Sedlarikova, Lenka ^{[1
,4
]}

Oliva, Stefania ^{[3
]}

Gambella, Manuela ^{[3
]}

Omede, Paola ^{[5
]}

Adam, Zdenek ^{[6
]}

Pour, Ludek ^{[4
]}

Sevcikova, Sabina ^{[1
,4
]}

Boccadoro, Mario ^{[7
]}

Palumbo, Antonio ^{[3
]}

Hajek, Roman ^{[1
,6
,8
,9
]}

机构：

[1] Masaryk Univ, Fac Med, Dept Pathol Physiol, Babak Myeloma Grp, Brno, Czech Republic

[2] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic

[3] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Div Hematol, Turin, Italy

[4] Univ Hosp Brno, Brno, Czech Republic

[5] Univ Turin, AOU Citta Salute & Sci, Turin, Italy

[6] Univ Hosp, Brno, Czech Republic

[7] Univ Turin, Div Hematol, Myeloma Unit, Turin, Italy

[8] Univ Hosp Ostrava, Ostrava, Czech Republic

[9] Univ Ostrava, Fac Med, CZ-70103 Ostrava, Czech Republic

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choice
Owen, RG
Rawstron, AC
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (05) : 732 - 733
[42] Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma
Yang, Peiyu
Xu, Weiling
Liang, Xinyue
Yu, Shanshan
Yi, Xingcheng
Liu, Mengmeng
Tian, Mengru
Yue, Tingting
Zhang, Yingjie
Yan, Yurong
Hu, Zhongli
Guo, Qiang
Zhang, Nan
Wang, Jingxuan
Sun, Xiaoxiao
Hu, Rui
Kumar, Shaji K.
Dai, Yun
Jin, Fengyan
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (03) : E61 - E64
[43] Minimal residual disease clinical monitoring and depth of response in multiple myeloma.
Martinez-Lopez, Joaquin
Wong, Sandy Wai Kuan
Shah, Nina
Bahri, Natasha
Zhou, Kaili
Martin, Thomas G.
Wolf, Jeffrey Lee
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[44] MINIMAL RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA USING POLYCHROMATIC FLOW CYTOMETRY
Rihova, Lucie
Varmuzova, Tamara
Zarbochova, Pavla
Suska, Renata
Penka, Miroslav
Hajek, Roman
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (06) : 404 - 405
[45] Reference Materials for Measurable Residual Disease (MRD) Monitoring in Circulating Cell-Free DNA (ccfDNA)
Konigshofer, Y.
Butler, M.
Dickens, J.
Clement, O.
Anekella, B.
Garlick, R.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S89 - S89
[46] Monitoring mutant KRAS in plasma cell-free DNA can predict disease progression in a patient with multiple myeloma: A case report
Yamamoto, Masayo
Shindo, Motohiro
Funayama, Takuya
Sumi, Chihiro
Saito, Takeshi
Toki, Yasumichi
Hatayama, Mayumi
Ono, Yusuke
Sato, Kazuya
Mizukami, Yusuke
Okumura, Toshikatsu
CLINICA CHIMICA ACTA, 2023, 551
[47] Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics
Wang, Siwei
Xia, Zhijun
You, Jing
Gu, Xiaolan
Meng, Fanchen
Chen, Peng
Tang, Wanxiangfu
Bao, Hua
Zhang, Jingyuan
Wu, Xue
Shao, Yang
Wang, Jie
Zuo, Xianglin
Xu, Lin
Yin, Rong
CANCER RESEARCH COMMUNICATIONS, 2023, 3 (05): : 933 - 942
[48] Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: A retrospective study
Liu, Hong
Yuan, Constance
Heinerich, Jeremy
Braylan, Raul
Chang, Myron
Wingard, John
Moreb, Jan
LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 306 - 314
[49] MONITORING OF MINIMAL RESIDUAL DISEASE (MRD) IN PATIENTS WITH MULTIPLE MYELOMA (MM) BEFORE AND AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)
Galtseva, I.
Mendeleeva, L.
Pokrovskaya, O.
Kastrikina, I.
Urnova, E.
Kuzmina, L.
Parovichnikova, E.
Savchenko, V.
HAEMATOLOGICA, 2014, 99 : 647 - 647
[50] Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma
Fenk, R
Ak, M
Kobbe, G
Steidl, U
Arnold, C
Korthals, M
Hünerlitürkoglu, A
Rohr, UP
Kliszewski, S
Bernhardt, A
Haas, R
Kronenwett, R
HAEMATOLOGICA, 2004, 89 (05) : 557 - 566

← 1 2 3 4 5 →